NIH-funded research NIH-funded research

Role of gut E. coli in obesity and resistance to weight loss

Official title: The role of intestinal mucosal Escherichia coli in obesity and resistance to diet-induced weight loss

Funded at VA Greater Los Angeles Healthcare System · NIH-11188873 · Data updated 2026-11-12

A study with people who are obese and those at a healthy weight will examine how certain gut bacteria, especially Escherichia coli, relate to obesity and how they may affect ability to lose weight on a calorie-restricted diet.

More Obesity research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Greater Los Angeles Healthcare System
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2026
Project endMarch 31, 2030
Funding year2027
NIH project number1I01CX002659-01A2
Project IDNIH-11188873 on NIH RePORTER

Who could benefit from this research

Could help

Obese adults (BMI > 30) and healthy weight adults (BMI 20-25) undergoing colonoscopy who do not have inflammatory or cancerous findings.

Less likely to help

People not undergoing colonoscopy or with inflammatory/neoplastic findings may not directly benefit from this study.

What this research studies

Researchers will collect tissue samples from the intestines of 100 participants undergoing colonoscopy, including 50 obese individuals and 50 with normal weight. They will use advanced DNA sequencing and quantitative PCR to identify which bacteria are present and how abundant E. coli is in the mucosal lining. The goal is to see if obesity is linked to specific obesogenic E. coli strains and how these microbes might drive weight gain or hinder dieting, with findings guiding future interventions.

Why it matters

Potential benefit: If successful, results could lead to targeted microbiome strategies to support weight loss and obesity treatment.

How similar studies have gone: Previous work suggests specific gut microbes are linked to obesity, but this study will test mucosal E. coli in humans with robust sampling.

Where this research is happening

  • VA Greater Los Angeles Healthcare System
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Jacobs, Jonathan Patrick — VA Greater Los Angeles Healthcare System
  • Study coordinator: Jacobs, Jonathan Patrick

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.